280 related articles for article (PubMed ID: 19564419)
21. Enterovirus 2A
Kastan JP; Tremblay MW; Brown MC; Trimarco JD; Dobrikova EY; Dobrikov MI; Gromeier M
mBio; 2021 Apr; 12(2):. PubMed ID: 33849973
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
23. SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.
Zitzmann K; Brand S; De Toni EN; Baehs S; Göke B; Meinecke J; Spöttl G; Meyer HH; Auernhammer CJ
Cancer Res; 2007 May; 67(10):5025-32. PubMed ID: 17510435
[TBL] [Abstract][Full Text] [Related]
24. The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.
Ma Y; Wang C; Xue M; Fu F; Zhang X; Li L; Yin L; Xu W; Feng L; Liu P
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185587
[TBL] [Abstract][Full Text] [Related]
25. Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages.
Zou W; Kim JH; Handidu A; Li X; Kim KI; Yan M; Li J; Zhang DE
Biochem Biophys Res Commun; 2007 Apr; 356(1):193-9. PubMed ID: 17349616
[TBL] [Abstract][Full Text] [Related]
26. Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia.
Teramo A; Gattazzo C; Passeri F; Lico A; Tasca G; Cabrelle A; Martini V; Frezzato F; Trimarco V; Ave E; Boscaro E; Piazza F; Facco M; Trentin L; Semenzato G; Zambello R
Blood; 2013 May; 121(19):3843-54, S1. PubMed ID: 23515927
[TBL] [Abstract][Full Text] [Related]
27. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
28. The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist.
Read SA; Tay ES; Shahidi M; McLauchlan J; George J; Douglas MW
J Interferon Cytokine Res; 2015 Jun; 35(6):488-97. PubMed ID: 25734487
[TBL] [Abstract][Full Text] [Related]
29. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
[TBL] [Abstract][Full Text] [Related]
30. Kaempferol modulates IFN-γ induced JAK-STAT signaling pathway and ameliorates imiquimod-induced psoriasis-like skin lesions.
Li Y; Cui H; Li S; Li X; Guo H; Nandakumar KS; Li Z
Int Immunopharmacol; 2023 Jan; 114():109585. PubMed ID: 36527884
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of microRNA‑155 relieves sepsis‑induced liver injury through inactivating the JAK/STAT pathway.
Lv X; Zhang Y; Cui Y; Ren Y; Li R; Rong Q
Mol Med Rep; 2015 Oct; 12(4):6013-8. PubMed ID: 26251957
[TBL] [Abstract][Full Text] [Related]
32. Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.
Li L; Lei QS; Zhang SJ; Kong LN; Qin B
PLoS One; 2016; 11(5):e0156496. PubMed ID: 27227879
[TBL] [Abstract][Full Text] [Related]
33. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes.
Norkina O; Dolganiuc A; Catalano D; Kodys K; Mandrekar P; Syed A; Efros M; Szabo G
Alcohol Clin Exp Res; 2008 Sep; 32(9):1565-73. PubMed ID: 18616672
[TBL] [Abstract][Full Text] [Related]
34. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
Front Immunol; 2021; 12():748423. PubMed ID: 34691060
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.
Sharma ND; Nickl CK; Kang H; Ornatowski W; Brown R; Ness SA; Loh ML; Mullighan CG; Winter SS; Hunger SP; Cannon JL; Matlawska-Wasowska K
Cancer Sci; 2019 Jun; 110(6):1931-1946. PubMed ID: 30974024
[TBL] [Abstract][Full Text] [Related]
36. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.
Fan W; Xie S; Zhao X; Li N; Chang C; Li L; Yu G; Chi X; Pan Y; Niu J; Zhong J; Sun B
J Gen Virol; 2016 Sep; 97(9):2210-2220. PubMed ID: 27302182
[TBL] [Abstract][Full Text] [Related]
37. Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.
Honda M; Takehana K; Sakai A; Tagata Y; Shirasaki T; Nishitani S; Muramatsu T; Yamashita T; Nakamoto Y; Mizukoshi E; Sakai Y; Yamashita T; Nakamura M; Shimakami T; Yi M; Lemon SM; Suzuki T; Wakita T; Kaneko S;
Gastroenterology; 2011 Jul; 141(1):128-40, 140.e1-2. PubMed ID: 21458454
[TBL] [Abstract][Full Text] [Related]
38. Correlation between the suppressor of cytokine signaling-1 and 3 and hepatitis B virus: possible roles in the resistance to interferon treatment.
Du LY; Cui YL; Chen EQ; Cheng X; Liu L; Tang H
Virol J; 2014 Mar; 11():51. PubMed ID: 24636575
[TBL] [Abstract][Full Text] [Related]
39. ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.
Chen Y; Jiao B; Yao M; Shi X; Zheng Z; Li S; Chen L
Virus Res; 2017 Jan; 227():231-239. PubMed ID: 27777077
[TBL] [Abstract][Full Text] [Related]
40. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
